Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Dabeinong Technology Group is a leading Chinese agricultural high-tech enterprise specializing in animal nutrition, animal health, and seed biotechnology. The company is a major producer of high-quality animal feed and veterinary vaccines, particularly for the swine and poultry sectors. Dabeinong is a pioneer in China's crop biotechnology industry, having developed several genetically modified (GM) traits for corn and soybeans that provide insect resistance and herbicide tolerance. Through its robust R&D platform, the company focuses on enhancing agricultural productivity and ensuring food security. Publicly listed on the Shenzhen Stock Exchange, Dabeinong operates extensively within China and has expanded its footprint into international markets, notably in South America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Dabeinong.